Generate a tailored SOP for Dr. Dana Bliuc. Improve your application with a focused, well-structured draft.
Dana Bliuc is a clinical epidemiologist specialized in fracture epidemiology with over 15 years of expertise in the field. Her extensive research has focused on adverse outcomes associated with osteoporotic fractures, including the effectiveness and safety of osteoporosis medications in real-world settings. Dana's PhD research notably demonstrated the long-term adverse events linked to osteoporotic fractures, revealing the subsequent risk of fractures and premature mortality. Her work has significantly contributed to the development of fracture prevention guidelines and has highlighted the impact of nitrogen-bisphosphonates on mortality risk reduction. Currently, her research includes the importance of multimorbidity and osteoporosis medications, striving to improve quality of life post-fracture. Dana is also experienced in experimental design and data analysis, particularly in modelling complex longitudinal population-based cohorts using linked administrative datasets.
University of New South Wales • Sydney, Australia
Teaching and conducting research in clinical epidemiology and fracture epidemiology.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.